A novel ionizable lipid nanoparticle platform for circular RNA-encoded PD-L1×CD3 bispecific antibodies elicits potent antitumor immunity
aState Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
bDepartment of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610044, China
cTianfu Jincheng Laboratory, Chengdu 610093, China
收起